— Know what they know.
Not Investment Advice

PRVB NASDAQ

Provention Bio, Inc.
1W: +3.0% 1M: +4.3% 3M: +186.8% 1Y: +396.6% 3Y: +113.1%
$24.98
Last traded 2023-04-27 — delisted
NASDAQ · Healthcare · Biotechnology · $2.4B mcap · 70M float · 4.08% daily turnover

Balance Sheet Trends

Total Assets
$237M +74.6% ▲
5Y CAGR: +60.2%
Total Liabilities
$115M +362.1% ▲
5Y CAGR: +119.1%
Shareholders Equity
$122M +141.7% ▲
5Y CAGR: +43.3%
Cash & Investments
$165M +29.8% ▲
5Y CAGR: +49.9%
Total Debt
$24M +3952.5% ▲
Net Debt
-$20M +74.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$59M$39M$102M$78M$44M
Short-Term Investments$0$46M$20M$17M$121M
Cash & ST Investments$59M$85M$122M$127M$165M
Net Receivables$0$0$0$0$1M
Inventory$0$0$0$0$1M
Other Current Assets$3M$623K$5M$6M$7M
Total Current Assets$62M$86M$127M$101M$175M
Property, Plant & Equip.$0$0$2M$2M$3M
Goodwill & Intangibles$0$0$0$0$60M
Long-Term Investments$0$0$0$32M$0
Other Non-Current Assets$0$0$120K$120K$120K
Total Non-Current Assets$0$0$2M$35M$62M
Total Assets$62M-$75M$129M$136M$237M
— Liabilities —
Accounts Payable$568K$2M$8M$4M$7M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$6M$18M
Other Current Liabilities$1M$2M$9M$14M$66M
Total Current Liabilities$2M$4M$17M$23M$90M
Long-Term Debt$0$0$715K$590K$24M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$568K$0$715K$2M$25M
Total Liabilities$2M$4M$306M$25M$115M
— Equity —
Common Stock$4K$5K$6K$6K$9K
Retained Earnings-$36M-$79M-$178M-$292M-$406M
Accumulated OCI-$62M-$86M-$15K-$139K-$647K
Total Stockholders Equity$60M-$79M-$178M-$292M$122M
Total Liabilities & Equity$62M-$75M$129M-$267M$237M
— Key Metrics —
Total Debt$0$0$715K$590K$24M
Net Debt-$59M-$39M-$102M-$78M-$20M
Total Investments$0$46M$20M$49M$121M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms